Subscribe

News
Academy
Multimedia
Conferences
Publications
Partner Perspectives
Resources
Subscribe

Telehealth

Latest News

Mitja Alexander Linss, Karger Publishers

March 28th 2025

The Evolution of Healthcare Communication: Bridging the HCP-Patient Divide

By Mitja Alexander Linss

Key trends in healthcare communication to build trust between healthcare providers and their patients.

Peter Ax, UpScriptHealth

March 24th 2025

Tariffs and Drug Prices: Understanding the Impact on Pharmaceuticals

By Miranda Schmalfuhs

February 20th 2025

Social Media's Influence on Young Women's Reproductive Decisions

By Miranda Schmalfuhs

February 10th 2025

Revolutionizing Patient Adherence: Leveraging AI for Personalized Engagement

By Miranda Schmalfuhs

Latest Videos

Kimberley Chiang, CoverMyMeds

Balancing Technological & Human Support in Medication Access

Kimberley Chiang, CoverMyMeds

Proactively Identifying & Addressing Affordability Issues with Predictive Analytics

Kimberley Chiang, CoverMyMeds

Strategies to Address Rising Medication Costs & Improve Patient Access

Insights on UpScriptHealth’s Recent Pfizer Partnership & Its Impact on Drug Access

Insights on UpScriptHealth’s Recent Pfizer Partnership & Its Impact on Drug Access

Digital Health Platforms as Strategic Partners for Pharma Companies

Digital Health Platforms as Strategic Partners for Pharma Companies

Potential Tariff Impact on Availability & Accessibility of Medications for Telehealth Patients

Potential Tariff Impact on Availability & Accessibility of Medications for Telehealth Patients

How Tariffs Will Drive Up Pharmaceutical Costs & Which Drug Categories Will Be Most Affected

How Tariffs Will Drive Up Pharmaceutical Costs & Which Drug Categories Will Be Most Affected

More News

Trending on PharmExec

Aradhana Sarin: The CFO as a Catalyst

Amgen’s Tarlatamab Approved in China

Regeneron Enters $2.1 Billion Radiopharma Collaboration with Telix Pharmaceuticals

Managing Patient Experience and RWE in Clinical Trials: Q&A with Matt Holms, MB

Pharmaceutical Executive Daily: FDA Issues Second CRL for Replimune's RP1 Melanoma Treatment